Skip to main content
padlock icon - secure page this page is secure

Open Access Modeling multifactorial diseases using mouse subspecies strains

Download Article:
(PDF 155.2 kb)
As DNA sequencing becomes cheaper it becomes ever more realistic that analysing a person's genome may be an effective method of diagnosis and treatment. New and more accurate methods of measuring other important factors now exist, such as the state of the epigenome and the proteome of a person. Together, these technologies will form the cornerstone of personalised medicine that, at its best, could offer treatments that are precisely tuned to a person's needs. However, there are still many foundations that need to be laid before personalisation becomes an everyday reality. One such area is that of understanding currently unknown diseases and the link between genomics and the disease phenotype. There are many pathologies about which we know very little and for which it is difficult to find a treatment. At the same time, whilst we can document minute changes in the DNA sequence of an individual, we often cannot easily assign a particular downstream affect caused by a given change. Dr Takanori Amano of the RIKEN BioResource Research Center, Tsukuba, Japan, is currently leading a research team to better understand these unknown genotypes and diseases through the use of mouse models. The team is using mouse models to create realistic genomic representations of different, uncharacterised genomic changes, the focus is in the exploration of changes beyond those present within genes.
No References for this article.
No Supplementary Data.
No Article Media
No Metrics


Document Type: Research Article

Publication date: November 1, 2020

More about this publication?
  • Impact is a series of high-quality, open access and free to access science reports designed to enable the dissemination of research impact to key stakeholders. Communicating the impact and relevance of research projects across a large number of subjects in a content format that is easily accessible by an academic and stakeholder audience. The publication features content from the world's leading research councils, policy groups, universities and research projects. Impact is published under a CC-BY Creative Commons licence.

  • Subscribe to this Title
  • Terms & Conditions
  • Disseminating research in Impact
  • Information about Impact
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more